Navigation Links
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013
Date:10/28/2013

BOULDER, Colo., Oct. 28, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2014 and hold a conference call to discuss those results on Thursday, October 31, 2013.  Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)Conference Call InformationDate: Thursday, October 31, 2013Time: 9:00 a.m. eastern timeToll-Free: (877) 261-8990Toll: (847) 619-6441Pass Code: 35902809Webcast, including Replay and Conference Call Slides:
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhomeAbout Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company and currently expects significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.
Novartis began Phase 3 trials evaluating Array-invented MEK162 in patients with NRAS-mutant melanoma in July 2013 and in patients with BRAF-mutant melanoma in October 2013.  In addition, Array began a Phase 3 trial evaluating MEK162 in patients with low-grade serous ovarian cancer under the license agreement with Novartis in June 2013.  AstraZeneca began a pivotal trial with Array-invented selumetinib in patients with thyroid cancer in May 2013 and began a Phase 3 trial in patients with non-small cell lung cancer in October 2013.  Two other wholly-owned drugs, ARRY-520 and ARRY-614, are a
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
2. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
3. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
4. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
5. Gentris Corporation Launches Next Generation Human Transcriptome Array
6. Genentech Purchases Arrayit Technology
7. Arrayit on Major Fundraising Drive
8. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
9. Sequenom And CombiMatrix Announce Collaboration Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing
10. Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013 On August 7, 2013
11. Array Biopharma To Report Top-line Results From ARRY-502 Asthma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... Laboratories, will move its laboratory operations in ... Raleigh Durham , North Carolina.  Sequenom ... performed at the North Carolina ...
(Date:5/27/2015)... , May 27, 2015 PharmaPoint: Systemic ... and Market Analysis to 2022 - Event-Driven Update ... by generics and GlaxoSmithKline,s Benlysta is the only drug ... than 50 years. Following Benlysta,s launch, patients, uptake has ... Benlysta has managed to grow the lupus market in ...
(Date:5/27/2015)... 2015 Research and Markets ( ... "Asia Pacific Open System MRI Market - Growth, ... to their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... market is the fastest growing market for Open ... which is replacing CT because of its higher ...
Breaking Medicine Technology:Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3Asia Pacific Open System MRI Market Trends and Forecasts 2015-2019 2
... 7 Misonix, Inc. (Nasdaq: MSON ), a ... in Europe is used for the ablation of tumors ... into a new, three year, exclusive distribution agreement with ... of the BoneScalpel(TM) Ultrasonic Bone Cutter. , ...
... Conn., Oct. 7 Rib-X Pharmaceuticals, Inc., a company ... drugs for the treatment of multi-antibiotic resistant infections, today ... Advisory Board, Sterling Professor of Molecular Biophysics and Biochemistry ... Investigator, Thomas A. Steitz, Ph.D., has been awarded the ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland 2Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland 3Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry 2Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry 3Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry 4
(Date:5/27/2015)... 27, 2015 On June 5, Plan ... will partner with LifeSource to host Donate Your Break, ... place in a LifeSource donor coach outside of 116 ... p.m. , Demand for whole blood units is highest ... the summer months. LifeSource requires approximately 1,000 donations per ...
(Date:5/27/2015)... This is a professional and ... Omega-3 industry. The report provides a basic overview ... industry chain structure. The Omega-3 market analysis is ... competitive landscape analysis, and key regions development status. ... Company, Seadragon Marine Oils, Norwegian Fish Oil, Croda ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 ... its SonarMD Platform, a first-of-its kind, cloud-based ... managing patients with chronic gastrointestinal disease. , ... MBA, the application allows physicians to monitor ... the ongoing use of electronic health assessment ...
(Date:5/27/2015)... 27, 2015 “Heroin has never been more ... overdoses are coming from,” says Harford County Sheriff Jeff Gahler, ... 8th. In the surging heroin related incidents in Baltimore, police ... education to prevent heroin addiction and subsequent abuse before it ... Drug Rehab Baltimore is a drug and alcohol rehab facility ...
(Date:5/27/2015)... Fernando Valley, CA (PRWEB) May 27, 2015 ... , Dr. Peyman Ghasri, is now offering discounts on facial ... every year after the age of 18. This lost collagen ... eyes, sunken cheeks, wrinkles and expression lines. Facial fillers are ... volume. Many people turn to facial fillers to create a ...
Breaking Medicine News(10 mins):Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2
... College at Dallas report that contact lenses, both ... materials are expected to reduce the possibility of ... available now. Based in part on these findings, ... hyper-oxygen transmissible contact lenses for 30-day continuous wear.// ...
... way to stop the hair loss associated with drug treatment ... alopecia (CIA), is a frequent side effect of cancer therapy ... time in their lives.// ,Currently, there is no effective ... way doctors can attempt to minimise hair loss is to ...
... have found the genetic mutation that is to blame ... many people.The breakthrough could lead to the development of drugs ... more than one in twelve people suffer from some form ... a history of problems such as panic disorders, agoraphobia and ...
... clues to the high failure rate of cloning and ... core of the nucleus.The discovery, announced at the annual ... Science in Washington, shows that DNA has an internal ... provides clues to how active genes and 'junk DNA' ...
... study, exercise can help older people avert a form ... standing up and walking an impossible one.Those who regularly ... lose abilities to perform activities of daily living. ... Texas, this report is the first to demonstrate that ...
... have developed a screening technique for persons suffering from ... investigations of skin lesions may allow doctors to identify ... particularly those of the colon. ,By looking ... in members of families with a history of HNPCC ...
Cached Medicine News:Health News:New contact lens materials 2Health News:Breakthrough in cancer therapy 2Health News:The anxiety gene, 2Health News:DNA and clones 2Health News:Arthritis risk reduced by exercise 2
... is specifically designed for use on cystoscopy ... MicroTouch LP attaches to tables on the ... user complete freedom to move the patient ... of position of the instrument or interference ...
... a 3-axis digital stepper designed to ... facilitate interactive treatment planning. ,Digital registration ... probe location and movement, and template ... Capture dramatically reduces volume study time ...
... MYDON is a long-pulsed Nd:YAG laser system ... be used to treat deep-lying, superficial as well ... also well-suited for epilation in patients with darker ... hair as well as for general improvement of ...
... triple-mode technology makes BURANE XL ... an array of aesthetic laser ... patented, controllable mode for coagulation, ... ablation procedures, and in particular ...
Medicine Products: